Hospital or health organisation · founded 1996
Beth Israel Deaconess Medical Center
Boston, United States · bidmc.org
- Citations, last 5 years
- 285k
- Works, last 5 years
- 24.7k
- h-index
- 1,218
- Scientists listed
- 2 449
- Grants since 2016
- 2 336
Grants received
2016–2022 · research · R01
ApoJ as a novel hepatokine targeting muscle glucose metabolism
Young-Bum Kim · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2021 · research · R01
A Psychobiological Follow-up Study of Transition from Prodrome to Early Psychosis
Huijun Li · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2018 · research · R21
Measurement of Antibody Epitope Signatures by Peptide Microarrays to Determine Recency of HIV Infection
Timothy Jensen Henrich · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2022 · research · R01
MiR-199~214 cluster at the crossroads of plasticity and malignancy in breastcancer
Antoine Elias Karnoub · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2018 · research · R21
Monitoring contractile forces during airway constriction
Ramaswamy Krishnan · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2020 · research · R01
Proteomic Pathway Discovery in Cardiovascular Disease
Robert E Gerszten · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2020 · research · R01
Proteomic Pathway Discovery in Cardiovascular Disease
Robert E Gerszten · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2022 · research · R01
Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation
Muneeb Ahmed · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2021 · research · R01
Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation
Muneeb Ahmed · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2023 · research · R01
Skin Inflammatory Phenotypes as Biomarkers of Myocardial and Vascular Remodeling
Michael Jerosch-Herold · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2019 · research · R01
Advancing the Understanding of Postoperative Delirium Mechanisms via Multi-Omics
Towia A. Libermann · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2021 · research · R01
Exploiting Metabolic Vulnerabilities in the PI3K and Akt Pathway in Cancer for Therapeutic Benefit
Alex Toker · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2021 · research · R01
Skin Inflammatory Phenotypes as Biomarkers of Myocardial and Vascular Remodeling
Michael Jerosch-Herold · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2020 · research · R01
Role of biliverdin reductase during sterile inflammation in the liver.
Barbara Wegiel · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2021 · research · R01
Cortical Mechanisms of Headache: Beyond CSD
Rami Burstein · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2023 · research · R01
Cortical Mechanisms of Headache: Beyond CSD
Rami Burstein · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2021 · research · R01
A Psychobiological Follow-up Study of Transition from Prodrome to Early Psychosis
Huijun Li · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2019 · research · R01
Advancing the Understanding of Postoperative Delirium Mechanisms via Multi-Omics
Towia A. Libermann · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2021 · research · R01
Characterizing the signaling pathways that regulate Skp2 oncogenic function
Wenyi Wei · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2021 · research · R01
Proteomic Pathway Discovery in Cardiovascular Disease
Robert E Gerszten · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2021 · research · R01
Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation
Muneeb Ahmed · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2021 · cooperative agreement · UM1
Combined Immunologic Approaches to Cure HIV-1
Dan H. Barouch · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2021 · career development · K02
Characterization of broadly neutralizing antibodies against JC virus
Chen Sabrina Tan · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2021 · research · R01
MiR-199~214 cluster at the crossroads of plasticity and malignancy in breastcancer
Antoine Elias Karnoub · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2021 · research · R01
Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer
Reza Nezafat · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2021 · research · R01
Mechanisms of innate modulation of SIV reservoirs and opportunistic disease in the oral cavity
Roger Keith Reeves · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2021 · research · R01
A PSGL-1 Glycopeptide Mimetic for Treatment of Metabolic Syndrome
Elliot Chaikof · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2021 · research · R01
ERK Kinase Regulation of Insulin Signaling and Inflammation: Honing the Antidiabetic Effects of PPAR-gamma Activation
Alexander Banks · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2021 · career development · K01
Mechanisms Controlling BubR1 Regulation of Cancer and Aging
Brian J. North · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2021 · career development · K08
A multistakeholder examination of the drivers and value of inpatient consultation
Jennifer P Stevens · Beth Israel Deaconess Medical Center · funded by Agency for Healthcare Research and Quality
2016–2018 · research · R21
Quantitative Cardiac MRI for Detection of Subclinical Cardiotoxicity in Breast Cancer
Reza Nezafat · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2019 · research · R21
Antibody-based eradication of HIV from the CNS reservoirs
Chen Sabrina Tan · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2021 · research · R01
Targeting the APC/Cdc20 E3 ubiquitin ligase for chemoradiation sensitization
Wenyi Wei · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2018 · career development · K99
Investigation and functional characterization of new drivers of mesenchymal tumorigenesis.
Jlenia Guarnerio · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2020 · award
Regulation of Skp2 Oncogenic Functions by Acetylation in Breast Cancer
Hiroyuki Inuzuka · Beth Israel Deaconess Medical Center · funded by American Cancer Society
2016–2018 · research · R21
Brain Plasticity Measures in MCI
Alvaro Pascual-Leone · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2018 · research · R21
Brain Plasticity Measures in MCI
Alvaro Pascual-Leone · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2021 · research · R01
Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation
Muneeb Ahmed · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2021 · research · R01
ApoJ as a novel hepatokine targeting muscle glucose metabolism
Young-Bum Kim · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
2016–2025 · research · R01
Mechanisms for regulation of a novel class of anti-diabetic lipids
Barbara B. Kahn · Beth Israel Deaconess Medical Center · funded by National Institutes of Health
